Joel Batts, MA
Joel is a medical device industry veteran, with 20 years of leadership experience developing scientific and regulatory strategies for start-ups to large cap companies. He has delivered >$100 million return on investment by delivering FDA approvals for Class II and Class III devices in the musculoskeletal and wound care spaces. He has published and presented the results of pre-clinical and clinical science in journals such as American Journal of Sports Medicine, American Journal of Orthopaedics, and venues such as the American College of Foot and Ankle Surgeons. In 2010, he led a business development team in the application of a novel biologic material to osteoporotic patients for reducing the incidence of hip fractures. After conducting early-phase trials and developing the scientific and regulatory strategy, the team sold the technology for $30 million. He has also overseen key areas of investment and integration for four major acquisitions. Joel’s interests include the transformation of healthcare in developing countries of Africa, in partnership with the vision of LifeNet International. Joel earned a BS in exercise science from the University of Florida and an MA in bioethics and health policy from Loyola University Chicago Stritch School of Medicine.
Jason Inzana, PhD
Director | Science and Innovation
Jason is a biomedical engineering expert overseeing evidence strategy and development for Telos Partners. In this role, Dr. Inzana will facilitate the ongoing growth of the brand and support the company’s mission of threading the needle between scientific, regulatory, and publication objectives to accomplish client goals. Having completed doctoral studies in biomedical engineering at the University of Rochester and more than 20 peer-reviewed publications, Inzana brings a unique mix of scientific rigor and business acumen to the Telos Partners team. While serving as a research fellow with the AO Foundation in Davos, Switzerland, he worked closely with an interdisciplinary team of researchers on methods for optimizing orthopedic medical devices. At Zimmer Biomet, he led a range of evidence development initiatives resulting in scientific publications and regulatory approvals. An avid mountain climber and runner, Inzana understands the real world implications of advances in biomechanics and orthopedics, and is dedicated to disseminating evidence that will drive the next generation of health care solutions. “Building and telling the story of scientific evidence is the engine of technology adoption, access, and reimbursement,” stated Inzana. Jason earned his B.S. in Bioengineering from Cornell University and his M.S. and Ph.D. in Biomedical Engineering through the Center for Musculoskeletal Research at the University of Rochester.
Michael Dyle, PhD
Michael is a physiologist and writer with approximately 10 years of experience studying mechanisms and treatment of skeletal muscle disorders. Prior to joining Telos, Michael was a postdoctoral researcher at the University of Colorado, where he studied a pathway contributing to skeletal muscle deterioration in a common muscular dystrophy: FSHD. Michael also served as a Licensing Analyst Fellow with CU Innovations. In this role, he supported the development of new medical devices, pharmaceuticals, and research tools created by researchers on the Anschutz Medical Campus. Michael’s doctoral studies focused on discovering mechanisms that drive skeletal muscle atrophy during orthopedic injuries and aging. He was also part of a team that identified a natural small molecule found in tomatoes, tomatidine, as a compound that reduces muscle atrophy and improves muscle strength and mass. Michael earned a BA in Biology from Grinnell College, as well as a PhD in Molecular Physiology and Biophysics from the University of Iowa.
Director | Regulatory & Quality Intelligence
Rebecca is a Regulatory Affairs leader with extensive experience in cross functional teams for new product development and post-market activities. She is known for her ability to de-mystify the complex regulatory landscape for clients and guide them into rewarding, sustainable regulatory / quality pathways. Rebecca’s 10+ years of experience in the life sciences industry, includes overseeing all aspects of Regulatory Affairs and providing lead support for corporate quality system initiatives. She has authored 510(k) and Technical Files for Class II devices, led FDA inspections and supported ISO 13485 and customer audits. Additionally, she has developed and implemented corporate design control procedures, and mentored design engineers. Her previous employment includes NN Inc. (formerly Paragon Medical) and NuVasive Specialized Orthopedics, Inc. (formerly Ellipse Technologies) focusing on regulatory strategies and processes for global commercialization of medical devices. “I am excited to be joining the Telos team at a time in which the regulatory landscape is rapidly evolving. Together, I look forward to providing our clients with regulatory and quality strategies that confidently support their business initiatives.” Rebecca is current with her Regulatory Affairs Certification (RAC) and holds a Bachelor of Arts in Sociology from California State University, Long Beach, CA.
VP I Clinical Evidence Program
Patrick is a seasoned analytical and innovative business leader with broad experience developing clinical research strategies to ensure robust evidence generation for global market access and market development. Patrick brings over 15 years of experience in the design and execution of clinical trials for medical devices, biologics, human tissue and blood-based products. He has experience negotiating clinical trial design with the FDA, working with KOL’s to design studies and presenting results. Gathering input from regulatory, health economic, product development, scientific and marketing stakeholders, Patrick manages studies with the goal of gaining maximum value for the investment. Patrick also has extensive experience building and managing clinical teams to ensure timely executing of clinical projects while complying with GCP and regulatory requirements. He believes transparency and accountability are important in collaborating on any research project. Patrick earned a BA in Biology and MBS in Exercise Science – Biomechanics from the University of Colorado in Colorado Springs.